Newbridge Financial Services Group’s enVVeno Medical NVNO Stock Holding History

Newbridge Financial Services Group’s Portfolio NVNO Stock Details NVNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1	Closed	-$80	–	1356
2025 Q2	$80	Buy	+1	New	+$118	﹤0.01%	1285
2023 Q4	–	Sell	-1	Closed	-$108	–	1275
2023 Q3	$108	Hold	1	–	–	﹤0.01%	1247
2023 Q2	$62	Hold	1	–	–	﹤0.01%	1312
2023 Q1	$94	Hold	1	–	–	﹤0.01%	1363
2022 Q4	$102	Hold	1	–	–	﹤0.01%	1398
2022 Q3	$0	Hold	1	–	–	﹤0.01%	1446
2022 Q2	$0	Hold	1	–	–	﹤0.01%	1469
2022 Q1	$0	Hold	1	–	–	﹤0.01%	1517
2021 Q4	$0	Hold	1	–	–	﹤0.01%	1498
2021 Q3	$1K	Hold	1	–	–	﹤0.01%	1289
2021 Q2	$0	Hold	1	–	–	﹤0.01%	1487
2021 Q1	$1K	Hold	1	–	–	﹤0.01%	1300
2020 Q4	$1K	Hold	1	–	–	﹤0.01%	1047
2020 Q3	$0	Buy	+1	New	+$339	﹤0.01%	1047

Other funds holding NVNO

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Newbridge Financial Services Group's NVNO Position: Q3 2025 in Review

Newbridge Financial Services Group sold out of enVVeno Medical (NVNO) in Q3 2025, closing a stake of 1 share — an estimated $80 sold.

Newbridge Financial Services Group first reported a position in NVNO in Q3 2020 and held it in 14 quarters. The position peaked at $1K in Q3 2021. 36 funds tracked by Wall St. Rank hold NVNO as of Q3 2025.

Newbridge Financial Services Group reported no remaining enVVeno Medical position as of Q3 2025 after selling out during the quarter.
Newbridge Financial Services Group sold 1 enVVeno Medical share in Q3 2025, an estimated $80.
Newbridge Financial Services Group first reported a position in enVVeno Medical in Q3 2020 and held it in 14 quarters.
Newbridge Financial Services Group's enVVeno Medical position peaked at $1K in Q3 2021.
36 funds tracked by Wall St. Rank held enVVeno Medical as of Q3 2025.

Based on Newbridge Financial Services Group's 13F filing for Q3 2025, filed 13 Nov 2025.